Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study.
Julia RomanowskaKjetil BjornevikMarianna CorteseJulia A TuominenMagne SolheimAsieh Abolpour MofradJannicke IglandClemens R ScherzerTrond RiisePublished in: Neurology (2023)
This drug-wide study identified thirty-one drug classes that were associated with the PD risk change. It reveals links of renin-angiotensin system medications, vaccines, and corticosteroids with PD risk and suggests that monitoring drug usage using pharmacoepidemiology may allow identifying individuals with prodromal PD.